Podcast Index

Podcasts

Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.

Decera Clinical Education Oncology Podcast Decera Clinical Education Oncology Podcast Decera Clinical Education Bíblia em um ano Bíblia em um ano 4Ventos P3 Krim P3 Krim Sveriges Radio F.A.Z. Künstliche Intelligenz F.A.Z. Künstliche Intelligenz Frankfurter Allgemeine Zeitung V redakcii V redakcii Denník N Machtwechsel Machtwechsel Dagmar Rosenfeld und Robin Alexander Fezcast - The Saracens Supporters Podcast Fezcast - The Saracens Supporters Podcast Fezcast (SSA) Stark Integrity Stark Integrity Bob Wade Parenting Teenagers Untangled: The award-winning podcast for parents of tweens and teens, offering realistic, science-backed advice for calmer, more connected family life. Parenting Teenagers Untangled: The award-winning podcast for parents of tweens and teens, offering realistic, science-backed advice for calmer, more connected family life. Rachel Richards Contre Soirée par AnnaRvr Contre Soirée par AnnaRvr Anna Rvr In Good Company with Nicolai Tangen In Good Company with Nicolai Tangen Norges Bank Investment Management Karanlık Dosyalar Karanlık Dosyalar Podbee Media ワールドリポート NHKラジオ「マイあさ!」 ワールドリポート NHKラジオ「マイあさ!」 NHK (Japan Broadcasting Corporation) The Ryan Samuels Show The Ryan Samuels Show Ryan F Samuels Haken dran – das Social-Media-Update der c't Haken dran – das Social-Media-Update der c't Gavin Karlmeier 'ne Dosis Wissen | Der Medizin-Podcast für Menschen im Gesundheitswesen 'ne Dosis Wissen | Der Medizin-Podcast für Menschen im Gesundheitswesen Apotheken Umschau Pro & gesundheit-hören UK Health Radio Podcast UK Health Radio Podcast UK Health Radio Podcast Bubba and the Bloom Bubba and the Bloom Fantasy Baseball Padre José Augusto (OFICIAL) Padre José Augusto (OFICIAL) Homilias padre José Augusto 気になる現場 NHKラジオ「NHKジャーナル」 気になる現場 NHKラジオ「NHKジャーナル」 NHK (Japan Broadcasting Corporation) SøstreneTalling SøstreneTalling Podimo La Traque La Traque Bababam Hermans Ogenblik Hermans Ogenblik Dagblad van het Noorden Rewilding the World with Ben Goldsmith Rewilding the World with Ben Goldsmith Ben Goldsmith Create Your Balance with Literacy Create Your Balance with Literacy Kara M. Rickman The Kosher Terroir The Kosher Terroir Solomon Simon Jacob Pizza King Podcast: Empowering Pizzeria Leadership Pizza King Podcast: Empowering Pizzeria Leadership Tyrell Reed | Pizzeria Leadership & Team Building Coach أخبار بالعربي أخبار بالعربي SBS London Weather Daily London Weather Daily Fast Foundations BCG on Compliance BCG on Compliance Boston Consulting Group מקור להשראה: רעיון גדול באריזה קטנה מקור להשראה: רעיון גדול באריזה קטנה Beit Avi Chai Daily English Pod Daily English Pod Jale Qaraqan They Talk Tech – mit Eckert und Wolfangel They Talk Tech – mit Eckert und Wolfangel c't Magazin Being Cosmic Chaos Being Cosmic Chaos Cass sadece film izlemiyorum sadece film izlemiyorum Podbee Media What Did You Do Yesterday? with Max Rushden & David O'Doherty What Did You Do Yesterday? with Max Rushden & David O'Doherty Keep It Light Media Endlich Entspannt Erfolgreich Endlich Entspannt Erfolgreich Kora Dierichs
Decera Clinical Education Oncology Podcast

Todo

Decera Clinical Education Oncology Podcast

Decera Clinical Education

Incorporating AKT1 and PIK3CA Pathway Testing and Targeted Therapies in the Management of Advanced Endocrine-Resistant Breast Cancer

June 30, 2026 1:57pm 24 min

Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic bre...

Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider

June 22, 2026 10:16am 26 min

Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, inclu...

Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness

June 09, 2026 12:23pm 27 min

In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk populations, including: Low-dose CT screening, which reduces lung c...

HNSCC: Current and Emerging Therapeutic Strategies

May 29, 2026 4:01pm 26 min

In this episode,  Aarti Bhatia, MD, MPH, and  Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), incl...

Navigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific Antibodies

May 15, 2026 2:36pm 20 min

In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical differences among approved bispecific antibodies Toxicity profi...

Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma

May 07, 2026 8:14am 31 min

In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dos...

Thrombotic Events and ET/PV: What You Should Know

April 30, 2026 3:15pm 22 min

In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis:  PV and ET incre...

Global Experts Discuss Current and Emerging Treatments for ET and PV

April 30, 2026 3:08pm 17 min

In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, i...

Global Experts Discuss Diagnostic Considerations in ET and PV

April 29, 2026 3:02pm 14 min

In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including: Overview of diagn...

Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer

April 17, 2026 1:05pm 22 min

In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer...

Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes

April 15, 2026 3:55pm 41 min

A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patie...

Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities

April 15, 2026 12:57pm 31 min

Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic disease settings following current guidelines, indications, and be...

Patient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigation, Adherence, and Persistence in HR+/HER2- Breast Cancer

April 14, 2026 2:56pm 44 min

In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in HR-positive/HER2-negative breast cancer, with a focus on how oncology pharm...

TROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current Use in Clinical Practice and Future Directions

April 13, 2026 10:40am 33 min

In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment stra...

Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer

April 13, 2026 10:01am 39 min

In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer...

Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC

March 26, 2026 8:13am 19 min

In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including: Classifying HER2 expression in MBC today (HER2 negative/ultralo...

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer

March 25, 2026 3:46pm 33 min

Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and Kathleen Boyle, DScPAS, PA-C, about familial cancer syndromes associ...

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer

March 25, 2026 9:06am 22 min

Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC, AOCNP, about when to conduct germline and somatic genetic te...

Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026

March 23, 2026 2:19pm 18 min

In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the lat...

Myth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimization

March 20, 2026 12:38pm 25 min

In this episode, oncology pharmacists Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, explore and challenge common assumptions about adjuvant CDK4/6 inhibitor use in high-risk HR+/HER2- early breast ...

Envía tu emisora ​​favorita

Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.

Nombre
Categoría
Mantenga presionada la tecla Ctrl (Cmd en Mac) para seleccionar varios.
URL de transmisión
Logo (JPG, JPEG o PNG)

Contáctanos

Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.

Asunto
Tu nombre
Correo electrónico
URL de la emisora o de la página
Mensaje
Cuanto es 18 más 6?
También adjuntamos tu país, navegador, página actual y algunos datos técnicos para ayudarnos a investigar.